• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

色素性视网膜炎基因治疗中时间“不可逆转点”的小鼠模型。

Mouse Models of Achromatopsia in Addressing Temporal "Point of No Return" in Gene-Therapy.

机构信息

Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, NY 10032, USA.

Department of Ophthalmology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.

出版信息

Int J Mol Sci. 2021 Jul 28;22(15):8069. doi: 10.3390/ijms22158069.

DOI:10.3390/ijms22158069
PMID:34360834
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8347118/
Abstract

Achromatopsia is characterized by amblyopia, photophobia, nystagmus, and color blindness. Previous animal models of achromatopsia have shown promising results using gene augmentation to restore cone function. However, the optimal therapeutic window to elicit recovery remains unknown. Here, we attempted two rounds of gene augmentation to generate recoverable mouse models of achromatopsia including a model with a knock-in stop cassette in intron 5 using -CRISPR (fficient dditions with sDNA nserts-CRISPR) and targeted embryonic stem (ES) cells. This model demonstrated that only 20% of CNGA3 levels in homozygotes derived from target ES cells remained, as compared to normal CNGA3 levels. Despite the low percentage of remaining protein, the knock-in mouse model continued to generate normal cone phototransduction. Our results showed that a small amount of normal CNGA3 protein is sufficient to form "functional" CNG channels and achieve physiological demand for proper cone phototransduction. Thus, it can be concluded that mutating the locus to disrupt the functional tetrameric CNG channels may ultimately require more potent STOP cassettes to generate a reversible achromatopsia mouse model. Our data also possess implications for future -associated achromatopsia clinical trials, whereby restoration of only 20% functional CNGA3 protein may be sufficient to form functional CNG channels and thus rescue cone response.

摘要

全色盲的特征是弱视、畏光、眼球震颤和色盲。以前的全色盲动物模型通过基因增强来恢复锥体细胞功能显示出了有前景的结果。然而,诱发恢复的最佳治疗窗口仍然未知。在这里,我们尝试了两轮基因增强,以生成可恢复的全色盲小鼠模型,包括使用 -CRISPR(带有 sDNA 插入的有效添加-CRISPR)和靶向胚胎干细胞(ES 细胞)在 5 号内含子中敲入终止密码子的模型。该模型表明,与正常的 CNGA3 水平相比,仅来自靶向 ES 细胞的纯合子中保留了 20%的 CNGA3 水平。尽管剩余蛋白的百分比很低,但敲入小鼠模型仍继续产生正常的锥体细胞光转导。我们的结果表明,少量正常的 CNGA3 蛋白足以形成“功能性”CNG 通道,并满足适当的锥体细胞光转导的生理需求。因此,可以得出结论,突变 基因座以破坏功能性四聚体 CNG 通道可能最终需要更有效的 STOP 盒来生成可逆转的全色盲小鼠模型。我们的数据也对未来与 相关的全色盲临床试验具有启示意义,其中仅恢复 20%的功能性 CNGA3 蛋白可能足以形成功能性 CNG 通道,从而挽救锥体细胞反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69af/8347118/170e21438372/ijms-22-08069-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69af/8347118/e9160ed4ccd3/ijms-22-08069-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69af/8347118/403676cb2645/ijms-22-08069-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69af/8347118/0f77073df85e/ijms-22-08069-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69af/8347118/d9bfd9a13458/ijms-22-08069-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69af/8347118/6fcb9e20650b/ijms-22-08069-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69af/8347118/46a65d76744d/ijms-22-08069-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69af/8347118/170e21438372/ijms-22-08069-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69af/8347118/e9160ed4ccd3/ijms-22-08069-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69af/8347118/403676cb2645/ijms-22-08069-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69af/8347118/0f77073df85e/ijms-22-08069-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69af/8347118/d9bfd9a13458/ijms-22-08069-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69af/8347118/6fcb9e20650b/ijms-22-08069-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69af/8347118/46a65d76744d/ijms-22-08069-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69af/8347118/170e21438372/ijms-22-08069-g002.jpg

相似文献

1
Mouse Models of Achromatopsia in Addressing Temporal "Point of No Return" in Gene-Therapy.色素性视网膜炎基因治疗中时间“不可逆转点”的小鼠模型。
Int J Mol Sci. 2021 Jul 28;22(15):8069. doi: 10.3390/ijms22158069.
2
AAV-mediated cone rescue in a naturally occurring mouse model of CNGA3-achromatopsia.AAV 介导的 cone 拯救在自然发生的 CNGA3-色盲小鼠模型中。
PLoS One. 2012;7(4):e35250. doi: 10.1371/journal.pone.0035250. Epub 2012 Apr 11.
3
Vitreal delivery of AAV vectored Cnga3 restores cone function in CNGA3-/-/Nrl-/- mice, an all-cone model of CNGA3 achromatopsia.通过玻璃体注射携带CNGA3的腺相关病毒载体可恢复CNGA3 - / - /Nrl - / -小鼠(一种全视锥细胞型CNGA3性全色盲模型)的视锥细胞功能。
Hum Mol Genet. 2015 Jul 1;24(13):3699-707. doi: 10.1093/hmg/ddv114. Epub 2015 Apr 8.
4
Accessory heterozygous mutations in cone photoreceptor CNGA3 exacerbate CNG channel-associated retinopathy.辅助性的视锥细胞光感受器 CNGA3 杂合突变可加重 CNG 通道相关性视网膜病变。
J Clin Invest. 2018 Dec 3;128(12):5663-5675. doi: 10.1172/JCI96098. Epub 2018 Nov 12.
5
Mutations in CNGA3 impair trafficking or function of cone cyclic nucleotide-gated channels, resulting in achromatopsia.CNGA3基因的突变会损害视锥细胞环核苷酸门控通道的运输或功能,从而导致全色盲。
Hum Mutat. 2008 Oct;29(10):1228-36. doi: 10.1002/humu.20790.
6
Six Years and Counting: Restoration of Photopic Retinal Function and Visual Behavior Following Gene Augmentation Therapy in a Sheep Model of Achromatopsia.六年及以后:在先天性色盲羊模型中进行基因增强治疗后,视敏度视网膜功能和视觉行为的恢复。
Hum Gene Ther. 2018 Dec;29(12):1376-1386. doi: 10.1089/hum.2018.076. Epub 2018 Jul 30.
7
CNGA3 achromatopsia-associated mutation potentiates the phosphoinositide sensitivity of cone photoreceptor CNG channels by altering intersubunit interactions.CNGA3 关联性色盲突变通过改变亚基间相互作用增强了锥光感受器 CNG 通道的磷酸肌醇敏感性。
Am J Physiol Cell Physiol. 2013 Jul 15;305(2):C147-59. doi: 10.1152/ajpcell.00037.2013. Epub 2013 Apr 3.
8
High-Throughput Ca Flux Assay To Monitor Cyclic Nucleotide-Gated Channel Activity and Characterize Achromatopsia Mutant Channel Function.高通量钙通量测定法监测环核苷酸门控通道活性和分析色盲突变体通道功能。
ACS Chem Neurosci. 2019 Aug 21;10(8):3662-3670. doi: 10.1021/acschemneuro.9b00231. Epub 2019 Jul 24.
9
An early nonsense mutation facilitates the expression of a short isoform of CNGA3 by alternative translation initiation.早期的无意义突变通过选择性翻译起始促进了 CNGA3 的短亚型的表达。
Exp Eye Res. 2018 Jun;171:48-53. doi: 10.1016/j.exer.2018.02.027. Epub 2018 Feb 27.
10
The cGMP-Dependent Protein Kinase 2 Contributes to Cone Photoreceptor Degeneration in the -Deficient Mouse Model of Achromatopsia.cGMP 依赖性蛋白激酶 2 导致 -/- 型先天性静止性夜盲症小鼠模型中视锥细胞光感受器变性。
Int J Mol Sci. 2020 Dec 23;22(1):52. doi: 10.3390/ijms22010052.

引用本文的文献

1
Spatiotemporal control of genome engineering in cone photoreceptors.视锥光感受器中基因组工程的时空控制。
Cell Biosci. 2023 Jun 28;13(1):119. doi: 10.1186/s13578-023-01033-3.
2
Prokineticin 2 as a potential biomarker for the diagnosis of Kawasaki disease.促动力蛋白2作为川崎病诊断的潜在生物标志物。
Clin Exp Med. 2023 Nov;23(7):3443-3451. doi: 10.1007/s10238-023-01078-1. Epub 2023 May 15.
3
HIF2α activation and mitochondrial deficit due to iron chelation cause retinal atrophy.铁螯合导致 HIF2α 激活和线粒体缺陷,从而引起视网膜萎缩。

本文引用的文献

1
Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trial.CNGA3 突变性无色素性视网膜炎的 I 期视网膜基因治疗试验的 3 年结果:一项非随机对照试验的结果。
Br J Ophthalmol. 2022 Nov;106(11):1567-1572. doi: 10.1136/bjophthalmol-2021-319067. Epub 2021 May 18.
2
Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled Trial.针对无色素性视锥细胞营养不良的视网膜下基因治疗的安全性和视觉效果:一项非随机对照试验。
JAMA Ophthalmol. 2020 Jun 1;138(6):643-651. doi: 10.1001/jamaophthalmol.2020.1032.
3
EMBO Mol Med. 2023 Feb 8;15(2):e16525. doi: 10.15252/emmm.202216525. Epub 2023 Jan 16.
A Novel Achromatopsia Mouse Model Resulting From a Naturally Occurring Missense Change in Cngb3.
一种新型的色觉缺失症小鼠模型,由 Cngb3 中自然发生的错义变化引起。
Invest Ophthalmol Vis Sci. 2018 Dec 3;59(15):6102-6110. doi: 10.1167/iovs.18-24328.
4
Rod Monochromatism (Achromatopsia).杆状单色视(色盲)。
Adv Exp Med Biol. 2018;1085:119-123. doi: 10.1007/978-3-319-95046-4_24.
5
Development of Methodology and Study Protocol: Safety and Efficacy of a Single Subretinal Injection of rAAV.hCNGA3 in Patients with CNGA3-Linked Achromatopsia Investigated in an Exploratory Dose-Escalation Trial.方法学与研究方案的制定:在一项探索性剂量递增试验中研究单次视网膜下注射rAAV.hCNGA3治疗CNGA3相关全色盲患者的安全性和有效性。
Hum Gene Ther Clin Dev. 2018 Sep;29(3):121-131. doi: 10.1089/humc.2018.088.
6
Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements.CRISPR-Cas9 诱导的双链断裂的修复会导致大片段缺失和复杂重排。
Nat Biotechnol. 2018 Sep;36(8):765-771. doi: 10.1038/nbt.4192. Epub 2018 Jul 16.
7
Retinal Cyclic Nucleotide-Gated Channels: From Pathophysiology to Therapy.视网膜环核苷酸门控通道:从病理生理学到治疗。
Int J Mol Sci. 2018 Mar 7;19(3):749. doi: 10.3390/ijms19030749.
8
Assessment of Murine Retinal Function by Electroretinography.通过视网膜电图评估小鼠视网膜功能。
Bio Protoc. 2017 Apr 5;7(7). doi: 10.21769/BioProtoc.2218.
9
Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins.Easi-CRISPR:一种使用长链单链DNA供体和CRISPR核糖核蛋白一步生成携带条件性和插入等位基因小鼠的强大方法。
Genome Biol. 2017 May 17;18(1):92. doi: 10.1186/s13059-017-1220-4.
10
CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa.CRISPR修复揭示色素性视网膜炎临床前模型中的致病突变。
Mol Ther. 2016 Aug;24(8):1388-94. doi: 10.1038/mt.2016.107. Epub 2016 May 20.